GNRH2 and ovarian carcinoma: Treating SKOV-3 cells with either GnRH1 or GnRH2 led to reduced MMP-2 expression and increased secretion of tissue inhibitor of MMP-2 (TIMP2), both important mediators of ovarian carcinoma metastasis (81).